Recovery of CMV-Specific CD8+ T Cells and Tregs after Allogeneic Peripheral Blood Stem Cell Transplantation
Open Access
- 30 April 2011
- journal article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 17 (4), 550-557
- https://doi.org/10.1016/j.bbmt.2010.04.011
Abstract
No abstract availableKeywords
Funding Information
- (Associazione Italiana contro le Leucemie, Linfomi e Mieloma)
This publication has 30 references indexed in Scilit:
- Viral disease prevention after hematopoietic cell transplantationBone Marrow Transplantation, 2009
- How we treat cytomegalovirus in hematopoietic cell transplant recipientsBlood, 2009
- The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapyBlood, 2004
- Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell linesThe Lancet, 2003
- Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategiesTransplantation and Cellular Therapy, 2003
- Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunityBlood, 2003
- Cytomegalovirus‐Specific Cellular Immune Responses and Viremia in Recipients of Allogeneic Stem Cell TransplantsThe Journal of Infectious Diseases, 2001
- Status of Cytomegalovirus Prevention and Treatment in 2000Hematology-American Society Hematology Education Program, 2000
- Neutropenia in Allogeneic Marrow Transplant Recipients Receiving Ganciclovir for Prevention of Cytomegalovirus Disease: Risk Factors and OutcomeBlood, 1997
- Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxisBlood, 1994